Virtus Investment Advisers, LLC

HARTFORD, CT · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 12, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$452.8M2026 Q3
Positions458
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.9.5%

Virtus Investment Advisers, LLC reported 458 positions worth $452.8M as of September 30, 2026 (13F filed November 12, 2026). Largest holding: MRNA (1.4%).

10 / 458 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 MRNAModerna$6.5M1.44%33,770——+11.8%
▸ 2 IOVAIovance Biotherapeutics$6.1M1.35%413,111——-49.1%
▸ 3 REGNRegeneron Pharmaceuticals$4.2M0.92%5,490——+25.6%
▸ 4 GILDGilead Sciences$4.1M0.91%27,587——+12.4%
▸ 5 AMGNAmgen$4.0M0.89%9,586——+9.7%
▸ 6 VRTXVertex Pharmaceuticals Inc$4.0M0.89%7,668——+2.9%
▸ 7 OMEROmeros$3.7M0.81%192,959——-8.1%
▸ 8 INCYIncyte$3.7M0.81%30,177——-0.9%
▸ 9 BMRNBiomarin Pharmaceutical$3.6M0.81%60,783——-3.3%
▸ 10 VSTMVerastem$3.3M0.73%411,097——-4.3%

Pro Feature

The remaining 448 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Virtus Investment Advisers, LLC hold as of Q3 2026?

Virtus Investment Advisers, LLC reported 458 positions worth $452.8M in its Q3 2026 13F filing. Largest positions: MRNA (1.4%), IOVA (1.4%), REGN (0.9%), GILD (0.9%) and AMGN (0.9%).

What did Virtus Investment Advisers, LLC buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Virtus Investment Advisers, LLC sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.